Delayed Delivery Of Vaccines Procured By Africa CDC Threatens Timeline For Achieving ‘Herd Immunity’ 17/03/2021 Paul Adepoju Africa’s goal of achieving herd immunity against COVID-19 hangs in the balance as 270 million doses of vaccines are yet to arrive in the continent despite being secured three months ago by the African Union (AU) and African Centres for Diseae Control (ACDC). Mid-January 2021, Health Policy Watch reported that the Africa CDC had […] Continue reading -> South Africa Vaccine Rollout: Health Worker Jabs Inch Forward – But With Insufficient Doses For Everyone 17/03/2021 Kerry Cullinan South Africa’s vaccination programme for health workers is inching forward, fuelled by small deliveries of the Johnson & Johnson vaccine every two weeks. However, overall supplies remain far short of the needs – even for the health sector. The country has an estimated 1.25 million health workers in public and private health to serve its […] Continue reading -> European Union Sharply Divided Over AstraZeneca Rollout – Despite Lack Of Documented Link to Higher Blood Clot Risks 16/03/2021 Raisa Santos Major European nations remain divided over the use of Oxford/AstraZeneca’s COVID-19 vaccine, while the pharma company said there was no evidence of increased risk of blood clotting and abnormal bleeding among people who get the vaccine. AstraZeneca’s review of all the safety data of more than 17 million people vaccinated in the European Union (EU) […] Continue reading -> Novavax Vaccine Shows Less Efficacy Against COVID Variants – Sputnik Vaccine to Be Produced In Italy 14/03/2021 Madeleine Hoecklin Novavax’s COVID-19 vaccine candidate has an efficacy rate of 96.4% against the original strain of SARS-CoV2. However, the efficacy rate drops up to 55.4% against the new B.1351 variant first identified in South Africa, and also spreading globally. The pharma company, which has never brought a vaccine to market before, published the data from two […] Continue reading -> More Investments Needed To Fight Covid-19 And Further Disease Outbreaks 09/03/2021 Chandre Prince African governments, the private sector, and development partners need to invest more in health and health systems to intensify the fight against the COVID-19 pandemic and any future disease outbreaks, according to health experts speaking at the African Health Agenda International Conference (AHAIC) on Tuesday. The experts agreed that a comprehensive, multi-sectoral approach is needed […] Continue reading -> European Medicines Agency Urges EU Member States To Postpone National Rollouts Of Russian Sputnik V Vaccine 08/03/2021 Madeleine Hoecklin A senior official at the European Medicines Agency (EMA) has cautioned EU member states to wait until the agency has reviewed the safety and efficacy data of Russia’s Sputnik V vaccine before granting the vaccine emergency use authorization at national level, and beginning mass rollouts. Last week, the EMA formally began a rolling review of […] Continue reading -> WHO Offers To Play ‘Matchmaker’ For Pharma Companies to Close Vaccine Production Gaps 05/03/2021 Kerry Cullinan The World Health Organization (WHO) and its COVAX partners are hosting a summit next week with governments and pharmaceutical companies to address the bottlenecks in COVID-19 vaccine production and delivery. This follows a spectacular start in the past week for COVAX, the global vaccine delivery platform, which delivered more than 20 million doses of COVID-19 […] Continue reading -> AstraZeneca Vaccine Sharply Reduces Symptomatic COVID-19 In Older Adults; India’s ‘Covaxin’ Vaccine Reported To Be 81% Efficacious – First Interim Analysis 03/03/2021 Raisa Santos & Elaine Ruth Fletcher The AstraZeneca/Oxford vaccine can reduce severe COVID-19 in older adults by up to 70%, says a new Public Health England (PHE) study – which offers the first real-world evidence of the effectiveness of the vaccine in preventing serious disease among older adults, following its approval by UK and European regulatory agencies. Findings about the efficacy […] Continue reading -> COVAX Aims to Distribute 237-million Vaccine Doses By May 02/03/2021 Sindie Mhlophe The global vaccine platform, COVAX, aims to distribute 237 million doses of the Oxford/ AstraZeneca vaccine to 142 countries by the end of May 2021, its managing partners told the media on Tuesday. Eleven million doses will be delivered this week alone, with Angola, Cambodia, Democratic Republic of Congo and Nigeria getting their vaccines on […] Continue reading -> Ambitious Global COVAX Facility Delivers First Doses In Accra Ghana 24/02/2021 Elaine Ruth Fletcher, Svĕt Lustig Vijay & Paul Adepoju Under cloudy skies, Ghana’s first precious doses of Covid-19 vaccines arrived Wednesday morning at Accra’s Kotoka International Airport. They are also the first supplies to be distributed by the WHO co-sponsored COVAX facility on the African continent. The arrival of some 600,000 vaccines marks a milestone in months of effort by WHO, UNICEF, GAVI and […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
South Africa Vaccine Rollout: Health Worker Jabs Inch Forward – But With Insufficient Doses For Everyone 17/03/2021 Kerry Cullinan South Africa’s vaccination programme for health workers is inching forward, fuelled by small deliveries of the Johnson & Johnson vaccine every two weeks. However, overall supplies remain far short of the needs – even for the health sector. The country has an estimated 1.25 million health workers in public and private health to serve its […] Continue reading -> European Union Sharply Divided Over AstraZeneca Rollout – Despite Lack Of Documented Link to Higher Blood Clot Risks 16/03/2021 Raisa Santos Major European nations remain divided over the use of Oxford/AstraZeneca’s COVID-19 vaccine, while the pharma company said there was no evidence of increased risk of blood clotting and abnormal bleeding among people who get the vaccine. AstraZeneca’s review of all the safety data of more than 17 million people vaccinated in the European Union (EU) […] Continue reading -> Novavax Vaccine Shows Less Efficacy Against COVID Variants – Sputnik Vaccine to Be Produced In Italy 14/03/2021 Madeleine Hoecklin Novavax’s COVID-19 vaccine candidate has an efficacy rate of 96.4% against the original strain of SARS-CoV2. However, the efficacy rate drops up to 55.4% against the new B.1351 variant first identified in South Africa, and also spreading globally. The pharma company, which has never brought a vaccine to market before, published the data from two […] Continue reading -> More Investments Needed To Fight Covid-19 And Further Disease Outbreaks 09/03/2021 Chandre Prince African governments, the private sector, and development partners need to invest more in health and health systems to intensify the fight against the COVID-19 pandemic and any future disease outbreaks, according to health experts speaking at the African Health Agenda International Conference (AHAIC) on Tuesday. The experts agreed that a comprehensive, multi-sectoral approach is needed […] Continue reading -> European Medicines Agency Urges EU Member States To Postpone National Rollouts Of Russian Sputnik V Vaccine 08/03/2021 Madeleine Hoecklin A senior official at the European Medicines Agency (EMA) has cautioned EU member states to wait until the agency has reviewed the safety and efficacy data of Russia’s Sputnik V vaccine before granting the vaccine emergency use authorization at national level, and beginning mass rollouts. Last week, the EMA formally began a rolling review of […] Continue reading -> WHO Offers To Play ‘Matchmaker’ For Pharma Companies to Close Vaccine Production Gaps 05/03/2021 Kerry Cullinan The World Health Organization (WHO) and its COVAX partners are hosting a summit next week with governments and pharmaceutical companies to address the bottlenecks in COVID-19 vaccine production and delivery. This follows a spectacular start in the past week for COVAX, the global vaccine delivery platform, which delivered more than 20 million doses of COVID-19 […] Continue reading -> AstraZeneca Vaccine Sharply Reduces Symptomatic COVID-19 In Older Adults; India’s ‘Covaxin’ Vaccine Reported To Be 81% Efficacious – First Interim Analysis 03/03/2021 Raisa Santos & Elaine Ruth Fletcher The AstraZeneca/Oxford vaccine can reduce severe COVID-19 in older adults by up to 70%, says a new Public Health England (PHE) study – which offers the first real-world evidence of the effectiveness of the vaccine in preventing serious disease among older adults, following its approval by UK and European regulatory agencies. Findings about the efficacy […] Continue reading -> COVAX Aims to Distribute 237-million Vaccine Doses By May 02/03/2021 Sindie Mhlophe The global vaccine platform, COVAX, aims to distribute 237 million doses of the Oxford/ AstraZeneca vaccine to 142 countries by the end of May 2021, its managing partners told the media on Tuesday. Eleven million doses will be delivered this week alone, with Angola, Cambodia, Democratic Republic of Congo and Nigeria getting their vaccines on […] Continue reading -> Ambitious Global COVAX Facility Delivers First Doses In Accra Ghana 24/02/2021 Elaine Ruth Fletcher, Svĕt Lustig Vijay & Paul Adepoju Under cloudy skies, Ghana’s first precious doses of Covid-19 vaccines arrived Wednesday morning at Accra’s Kotoka International Airport. They are also the first supplies to be distributed by the WHO co-sponsored COVAX facility on the African continent. The arrival of some 600,000 vaccines marks a milestone in months of effort by WHO, UNICEF, GAVI and […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
European Union Sharply Divided Over AstraZeneca Rollout – Despite Lack Of Documented Link to Higher Blood Clot Risks 16/03/2021 Raisa Santos Major European nations remain divided over the use of Oxford/AstraZeneca’s COVID-19 vaccine, while the pharma company said there was no evidence of increased risk of blood clotting and abnormal bleeding among people who get the vaccine. AstraZeneca’s review of all the safety data of more than 17 million people vaccinated in the European Union (EU) […] Continue reading -> Novavax Vaccine Shows Less Efficacy Against COVID Variants – Sputnik Vaccine to Be Produced In Italy 14/03/2021 Madeleine Hoecklin Novavax’s COVID-19 vaccine candidate has an efficacy rate of 96.4% against the original strain of SARS-CoV2. However, the efficacy rate drops up to 55.4% against the new B.1351 variant first identified in South Africa, and also spreading globally. The pharma company, which has never brought a vaccine to market before, published the data from two […] Continue reading -> More Investments Needed To Fight Covid-19 And Further Disease Outbreaks 09/03/2021 Chandre Prince African governments, the private sector, and development partners need to invest more in health and health systems to intensify the fight against the COVID-19 pandemic and any future disease outbreaks, according to health experts speaking at the African Health Agenda International Conference (AHAIC) on Tuesday. The experts agreed that a comprehensive, multi-sectoral approach is needed […] Continue reading -> European Medicines Agency Urges EU Member States To Postpone National Rollouts Of Russian Sputnik V Vaccine 08/03/2021 Madeleine Hoecklin A senior official at the European Medicines Agency (EMA) has cautioned EU member states to wait until the agency has reviewed the safety and efficacy data of Russia’s Sputnik V vaccine before granting the vaccine emergency use authorization at national level, and beginning mass rollouts. Last week, the EMA formally began a rolling review of […] Continue reading -> WHO Offers To Play ‘Matchmaker’ For Pharma Companies to Close Vaccine Production Gaps 05/03/2021 Kerry Cullinan The World Health Organization (WHO) and its COVAX partners are hosting a summit next week with governments and pharmaceutical companies to address the bottlenecks in COVID-19 vaccine production and delivery. This follows a spectacular start in the past week for COVAX, the global vaccine delivery platform, which delivered more than 20 million doses of COVID-19 […] Continue reading -> AstraZeneca Vaccine Sharply Reduces Symptomatic COVID-19 In Older Adults; India’s ‘Covaxin’ Vaccine Reported To Be 81% Efficacious – First Interim Analysis 03/03/2021 Raisa Santos & Elaine Ruth Fletcher The AstraZeneca/Oxford vaccine can reduce severe COVID-19 in older adults by up to 70%, says a new Public Health England (PHE) study – which offers the first real-world evidence of the effectiveness of the vaccine in preventing serious disease among older adults, following its approval by UK and European regulatory agencies. Findings about the efficacy […] Continue reading -> COVAX Aims to Distribute 237-million Vaccine Doses By May 02/03/2021 Sindie Mhlophe The global vaccine platform, COVAX, aims to distribute 237 million doses of the Oxford/ AstraZeneca vaccine to 142 countries by the end of May 2021, its managing partners told the media on Tuesday. Eleven million doses will be delivered this week alone, with Angola, Cambodia, Democratic Republic of Congo and Nigeria getting their vaccines on […] Continue reading -> Ambitious Global COVAX Facility Delivers First Doses In Accra Ghana 24/02/2021 Elaine Ruth Fletcher, Svĕt Lustig Vijay & Paul Adepoju Under cloudy skies, Ghana’s first precious doses of Covid-19 vaccines arrived Wednesday morning at Accra’s Kotoka International Airport. They are also the first supplies to be distributed by the WHO co-sponsored COVAX facility on the African continent. The arrival of some 600,000 vaccines marks a milestone in months of effort by WHO, UNICEF, GAVI and […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Novavax Vaccine Shows Less Efficacy Against COVID Variants – Sputnik Vaccine to Be Produced In Italy 14/03/2021 Madeleine Hoecklin Novavax’s COVID-19 vaccine candidate has an efficacy rate of 96.4% against the original strain of SARS-CoV2. However, the efficacy rate drops up to 55.4% against the new B.1351 variant first identified in South Africa, and also spreading globally. The pharma company, which has never brought a vaccine to market before, published the data from two […] Continue reading -> More Investments Needed To Fight Covid-19 And Further Disease Outbreaks 09/03/2021 Chandre Prince African governments, the private sector, and development partners need to invest more in health and health systems to intensify the fight against the COVID-19 pandemic and any future disease outbreaks, according to health experts speaking at the African Health Agenda International Conference (AHAIC) on Tuesday. The experts agreed that a comprehensive, multi-sectoral approach is needed […] Continue reading -> European Medicines Agency Urges EU Member States To Postpone National Rollouts Of Russian Sputnik V Vaccine 08/03/2021 Madeleine Hoecklin A senior official at the European Medicines Agency (EMA) has cautioned EU member states to wait until the agency has reviewed the safety and efficacy data of Russia’s Sputnik V vaccine before granting the vaccine emergency use authorization at national level, and beginning mass rollouts. Last week, the EMA formally began a rolling review of […] Continue reading -> WHO Offers To Play ‘Matchmaker’ For Pharma Companies to Close Vaccine Production Gaps 05/03/2021 Kerry Cullinan The World Health Organization (WHO) and its COVAX partners are hosting a summit next week with governments and pharmaceutical companies to address the bottlenecks in COVID-19 vaccine production and delivery. This follows a spectacular start in the past week for COVAX, the global vaccine delivery platform, which delivered more than 20 million doses of COVID-19 […] Continue reading -> AstraZeneca Vaccine Sharply Reduces Symptomatic COVID-19 In Older Adults; India’s ‘Covaxin’ Vaccine Reported To Be 81% Efficacious – First Interim Analysis 03/03/2021 Raisa Santos & Elaine Ruth Fletcher The AstraZeneca/Oxford vaccine can reduce severe COVID-19 in older adults by up to 70%, says a new Public Health England (PHE) study – which offers the first real-world evidence of the effectiveness of the vaccine in preventing serious disease among older adults, following its approval by UK and European regulatory agencies. Findings about the efficacy […] Continue reading -> COVAX Aims to Distribute 237-million Vaccine Doses By May 02/03/2021 Sindie Mhlophe The global vaccine platform, COVAX, aims to distribute 237 million doses of the Oxford/ AstraZeneca vaccine to 142 countries by the end of May 2021, its managing partners told the media on Tuesday. Eleven million doses will be delivered this week alone, with Angola, Cambodia, Democratic Republic of Congo and Nigeria getting their vaccines on […] Continue reading -> Ambitious Global COVAX Facility Delivers First Doses In Accra Ghana 24/02/2021 Elaine Ruth Fletcher, Svĕt Lustig Vijay & Paul Adepoju Under cloudy skies, Ghana’s first precious doses of Covid-19 vaccines arrived Wednesday morning at Accra’s Kotoka International Airport. They are also the first supplies to be distributed by the WHO co-sponsored COVAX facility on the African continent. The arrival of some 600,000 vaccines marks a milestone in months of effort by WHO, UNICEF, GAVI and […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
More Investments Needed To Fight Covid-19 And Further Disease Outbreaks 09/03/2021 Chandre Prince African governments, the private sector, and development partners need to invest more in health and health systems to intensify the fight against the COVID-19 pandemic and any future disease outbreaks, according to health experts speaking at the African Health Agenda International Conference (AHAIC) on Tuesday. The experts agreed that a comprehensive, multi-sectoral approach is needed […] Continue reading -> European Medicines Agency Urges EU Member States To Postpone National Rollouts Of Russian Sputnik V Vaccine 08/03/2021 Madeleine Hoecklin A senior official at the European Medicines Agency (EMA) has cautioned EU member states to wait until the agency has reviewed the safety and efficacy data of Russia’s Sputnik V vaccine before granting the vaccine emergency use authorization at national level, and beginning mass rollouts. Last week, the EMA formally began a rolling review of […] Continue reading -> WHO Offers To Play ‘Matchmaker’ For Pharma Companies to Close Vaccine Production Gaps 05/03/2021 Kerry Cullinan The World Health Organization (WHO) and its COVAX partners are hosting a summit next week with governments and pharmaceutical companies to address the bottlenecks in COVID-19 vaccine production and delivery. This follows a spectacular start in the past week for COVAX, the global vaccine delivery platform, which delivered more than 20 million doses of COVID-19 […] Continue reading -> AstraZeneca Vaccine Sharply Reduces Symptomatic COVID-19 In Older Adults; India’s ‘Covaxin’ Vaccine Reported To Be 81% Efficacious – First Interim Analysis 03/03/2021 Raisa Santos & Elaine Ruth Fletcher The AstraZeneca/Oxford vaccine can reduce severe COVID-19 in older adults by up to 70%, says a new Public Health England (PHE) study – which offers the first real-world evidence of the effectiveness of the vaccine in preventing serious disease among older adults, following its approval by UK and European regulatory agencies. Findings about the efficacy […] Continue reading -> COVAX Aims to Distribute 237-million Vaccine Doses By May 02/03/2021 Sindie Mhlophe The global vaccine platform, COVAX, aims to distribute 237 million doses of the Oxford/ AstraZeneca vaccine to 142 countries by the end of May 2021, its managing partners told the media on Tuesday. Eleven million doses will be delivered this week alone, with Angola, Cambodia, Democratic Republic of Congo and Nigeria getting their vaccines on […] Continue reading -> Ambitious Global COVAX Facility Delivers First Doses In Accra Ghana 24/02/2021 Elaine Ruth Fletcher, Svĕt Lustig Vijay & Paul Adepoju Under cloudy skies, Ghana’s first precious doses of Covid-19 vaccines arrived Wednesday morning at Accra’s Kotoka International Airport. They are also the first supplies to be distributed by the WHO co-sponsored COVAX facility on the African continent. The arrival of some 600,000 vaccines marks a milestone in months of effort by WHO, UNICEF, GAVI and […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
European Medicines Agency Urges EU Member States To Postpone National Rollouts Of Russian Sputnik V Vaccine 08/03/2021 Madeleine Hoecklin A senior official at the European Medicines Agency (EMA) has cautioned EU member states to wait until the agency has reviewed the safety and efficacy data of Russia’s Sputnik V vaccine before granting the vaccine emergency use authorization at national level, and beginning mass rollouts. Last week, the EMA formally began a rolling review of […] Continue reading -> WHO Offers To Play ‘Matchmaker’ For Pharma Companies to Close Vaccine Production Gaps 05/03/2021 Kerry Cullinan The World Health Organization (WHO) and its COVAX partners are hosting a summit next week with governments and pharmaceutical companies to address the bottlenecks in COVID-19 vaccine production and delivery. This follows a spectacular start in the past week for COVAX, the global vaccine delivery platform, which delivered more than 20 million doses of COVID-19 […] Continue reading -> AstraZeneca Vaccine Sharply Reduces Symptomatic COVID-19 In Older Adults; India’s ‘Covaxin’ Vaccine Reported To Be 81% Efficacious – First Interim Analysis 03/03/2021 Raisa Santos & Elaine Ruth Fletcher The AstraZeneca/Oxford vaccine can reduce severe COVID-19 in older adults by up to 70%, says a new Public Health England (PHE) study – which offers the first real-world evidence of the effectiveness of the vaccine in preventing serious disease among older adults, following its approval by UK and European regulatory agencies. Findings about the efficacy […] Continue reading -> COVAX Aims to Distribute 237-million Vaccine Doses By May 02/03/2021 Sindie Mhlophe The global vaccine platform, COVAX, aims to distribute 237 million doses of the Oxford/ AstraZeneca vaccine to 142 countries by the end of May 2021, its managing partners told the media on Tuesday. Eleven million doses will be delivered this week alone, with Angola, Cambodia, Democratic Republic of Congo and Nigeria getting their vaccines on […] Continue reading -> Ambitious Global COVAX Facility Delivers First Doses In Accra Ghana 24/02/2021 Elaine Ruth Fletcher, Svĕt Lustig Vijay & Paul Adepoju Under cloudy skies, Ghana’s first precious doses of Covid-19 vaccines arrived Wednesday morning at Accra’s Kotoka International Airport. They are also the first supplies to be distributed by the WHO co-sponsored COVAX facility on the African continent. The arrival of some 600,000 vaccines marks a milestone in months of effort by WHO, UNICEF, GAVI and […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Offers To Play ‘Matchmaker’ For Pharma Companies to Close Vaccine Production Gaps 05/03/2021 Kerry Cullinan The World Health Organization (WHO) and its COVAX partners are hosting a summit next week with governments and pharmaceutical companies to address the bottlenecks in COVID-19 vaccine production and delivery. This follows a spectacular start in the past week for COVAX, the global vaccine delivery platform, which delivered more than 20 million doses of COVID-19 […] Continue reading -> AstraZeneca Vaccine Sharply Reduces Symptomatic COVID-19 In Older Adults; India’s ‘Covaxin’ Vaccine Reported To Be 81% Efficacious – First Interim Analysis 03/03/2021 Raisa Santos & Elaine Ruth Fletcher The AstraZeneca/Oxford vaccine can reduce severe COVID-19 in older adults by up to 70%, says a new Public Health England (PHE) study – which offers the first real-world evidence of the effectiveness of the vaccine in preventing serious disease among older adults, following its approval by UK and European regulatory agencies. Findings about the efficacy […] Continue reading -> COVAX Aims to Distribute 237-million Vaccine Doses By May 02/03/2021 Sindie Mhlophe The global vaccine platform, COVAX, aims to distribute 237 million doses of the Oxford/ AstraZeneca vaccine to 142 countries by the end of May 2021, its managing partners told the media on Tuesday. Eleven million doses will be delivered this week alone, with Angola, Cambodia, Democratic Republic of Congo and Nigeria getting their vaccines on […] Continue reading -> Ambitious Global COVAX Facility Delivers First Doses In Accra Ghana 24/02/2021 Elaine Ruth Fletcher, Svĕt Lustig Vijay & Paul Adepoju Under cloudy skies, Ghana’s first precious doses of Covid-19 vaccines arrived Wednesday morning at Accra’s Kotoka International Airport. They are also the first supplies to be distributed by the WHO co-sponsored COVAX facility on the African continent. The arrival of some 600,000 vaccines marks a milestone in months of effort by WHO, UNICEF, GAVI and […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
AstraZeneca Vaccine Sharply Reduces Symptomatic COVID-19 In Older Adults; India’s ‘Covaxin’ Vaccine Reported To Be 81% Efficacious – First Interim Analysis 03/03/2021 Raisa Santos & Elaine Ruth Fletcher The AstraZeneca/Oxford vaccine can reduce severe COVID-19 in older adults by up to 70%, says a new Public Health England (PHE) study – which offers the first real-world evidence of the effectiveness of the vaccine in preventing serious disease among older adults, following its approval by UK and European regulatory agencies. Findings about the efficacy […] Continue reading -> COVAX Aims to Distribute 237-million Vaccine Doses By May 02/03/2021 Sindie Mhlophe The global vaccine platform, COVAX, aims to distribute 237 million doses of the Oxford/ AstraZeneca vaccine to 142 countries by the end of May 2021, its managing partners told the media on Tuesday. Eleven million doses will be delivered this week alone, with Angola, Cambodia, Democratic Republic of Congo and Nigeria getting their vaccines on […] Continue reading -> Ambitious Global COVAX Facility Delivers First Doses In Accra Ghana 24/02/2021 Elaine Ruth Fletcher, Svĕt Lustig Vijay & Paul Adepoju Under cloudy skies, Ghana’s first precious doses of Covid-19 vaccines arrived Wednesday morning at Accra’s Kotoka International Airport. They are also the first supplies to be distributed by the WHO co-sponsored COVAX facility on the African continent. The arrival of some 600,000 vaccines marks a milestone in months of effort by WHO, UNICEF, GAVI and […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
COVAX Aims to Distribute 237-million Vaccine Doses By May 02/03/2021 Sindie Mhlophe The global vaccine platform, COVAX, aims to distribute 237 million doses of the Oxford/ AstraZeneca vaccine to 142 countries by the end of May 2021, its managing partners told the media on Tuesday. Eleven million doses will be delivered this week alone, with Angola, Cambodia, Democratic Republic of Congo and Nigeria getting their vaccines on […] Continue reading -> Ambitious Global COVAX Facility Delivers First Doses In Accra Ghana 24/02/2021 Elaine Ruth Fletcher, Svĕt Lustig Vijay & Paul Adepoju Under cloudy skies, Ghana’s first precious doses of Covid-19 vaccines arrived Wednesday morning at Accra’s Kotoka International Airport. They are also the first supplies to be distributed by the WHO co-sponsored COVAX facility on the African continent. The arrival of some 600,000 vaccines marks a milestone in months of effort by WHO, UNICEF, GAVI and […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Ambitious Global COVAX Facility Delivers First Doses In Accra Ghana 24/02/2021 Elaine Ruth Fletcher, Svĕt Lustig Vijay & Paul Adepoju Under cloudy skies, Ghana’s first precious doses of Covid-19 vaccines arrived Wednesday morning at Accra’s Kotoka International Airport. They are also the first supplies to be distributed by the WHO co-sponsored COVAX facility on the African continent. The arrival of some 600,000 vaccines marks a milestone in months of effort by WHO, UNICEF, GAVI and […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy